
AIRS Medical Secures FDA Clearance for AI-Driven MRI Body Analysis
The U.S. Food and Drug Administration has granted 510(k) clearance to AIRS Medical for its SwiftSight Body Composition platform. By automating the quantification of muscle and adipose tissue through five-minute MRI scans, the technology allows imaging centers to offer standardized metabolic health assessments without requiring new hardware.





/https://www.ilsoftware.it/app/uploads/2024/05/xAI-Logo.png)






















